Atai Life Sciences Current Ratio 2020-2024 | ATAI
Atai Life Sciences current ratio from 2020 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Atai Life Sciences Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-09-30 |
$0.11B |
$0.02B |
5.81 |
| 2024-06-30 |
$0.12B |
$0.02B |
6.68 |
| 2024-03-31 |
$0.12B |
$0.02B |
7.83 |
| 2023-12-31 |
$0.19B |
$0.02B |
9.22 |
| 2023-09-30 |
$0.22B |
$0.02B |
10.96 |
| 2023-06-30 |
$0.24B |
$0.02B |
13.54 |
| 2023-03-31 |
$0.27B |
$0.02B |
13.43 |
| 2022-12-31 |
$0.29B |
$0.02B |
14.43 |
| 2022-09-30 |
$0.32B |
$0.03B |
12.25 |
| 2022-06-30 |
$0.32B |
$0.02B |
14.74 |
| 2022-03-31 |
$0.35B |
$0.02B |
15.79 |
| 2021-12-31 |
$0.38B |
$0.02B |
17.92 |
| 2021-09-30 |
$0.44B |
$0.02B |
28.85 |
| 2021-06-30 |
$0.46B |
$0.01B |
32.26 |
| 2021-03-31 |
$0.13B |
$0.02B |
6.88 |
| 2020-12-31 |
$0.10B |
$0.01B |
8.10 |
| 2020-09-30 |
$0.00B |
|
0.00 |
| 2020-06-30 |
$0.00B |
|
0.00 |
| 2020-03-31 |
$0.00B |
|
0.00 |
| 2019-12-31 |
$0.04B |
$0.00B |
24.36 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.252B |
$0.000B |
|
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|
